Skip to content
Tuesday, November 17, 2026 · Today’s edition, 6:30 a.m. ETTue, Nov 17 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in
ETF PRO AINovember 17, 2026

BBH VanEck Biotech ETF

Fund tearsheet · data as of the latest session · November 17, 2026

Print / save as PDFPrints clean — the site chrome stays behind.

ONE YEAR OF DAILY CLOSES

0.35%expense ratio
$535Mfund assets
+31.5%return, YTD
—return, 1 year
+$25Mnet flow, 1 month
+$39Mnet flow, 1 year
22.9%realized volatility, 1y
-10.5%worst drawdown, 1y
Top ten holdings
1AMGN AMGEN16.85%
2GILD GILEAD SCIENCES14.37%
3VRTX VERTEX PHARMACEUTICALS8.18%
4REGN REGENERON PHARMACEUTICALS7.92%
5MRNA MODERNA6.80%
6ARGX ARGENX SE4.44%
7IQV IQVIA HOLDINGS4.26%
8NTRA NATERA3.69%
9RVMD REVOLUTION MEDICINES3.42%
10ONC BeiGene3.04%

PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS

ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.